Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Minocycline studied in clinical trial for multiple sclerosis / News in Context

Oct. 27, 2006

SSR-180711 could ameliorate negative symptoms of schizophrenia

Oct. 27, 2006

Suven presents preclinical data on novel promising 5-HT6 receptor antagonists

Oct. 27, 2006

Preclinical studies show neuroprotective properties of ONO-2231 in animal models

Oct. 27, 2006

Enrollment placed on hold in phase IIb/III study of desmoteplase for stroke

Oct. 27, 2006

Topical local anesthetic 1207 begins clinical testing

Oct. 27, 2006

BrainCells to find new CNS applications for Organon compounds

Oct. 27, 2006

T-817MA protects neurons by activated PKC epsilon

Oct. 27, 2006

The glycine transporter-1 inhibitor SSR-103800 shows promise in animal models of schizophrenia

Oct. 26, 2006

Memory Pharmaceuticals discloses MEM-3454 preclinical data at the SfN meeting

Oct. 26, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...